These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23954252)

  • 1. Can pharmaco-electroencephalography help improve survival of central nervous system drugs in early clinical development?
    Wilson FJ; Leiser SC; Ivarsson M; Christensen SR; Bastlund JF
    Drug Discov Today; 2014 Mar; 19(3):282-8. PubMed ID: 23954252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Decision-Making in Drug Development: The Potential Role of Pharmaco-EEG and Pharmaco-Sleep.
    Wilson FJ; Danjou P
    Neuropsychobiology; 2015; 72(3-4):188-94. PubMed ID: 26900685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaco-EEG Studies in Animals: A History-Based Introduction to Contemporary Translational Applications.
    Drinkenburg WH; Ahnaou A; Ruigt GS
    Neuropsychobiology; 2015; 72(3-4):139-50. PubMed ID: 26901675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaco-electroencephalography in Phase I.
    Luthringer R; Boeijinga PH
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():95. PubMed ID: 12809085
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaco-EEG Studies in Animals: An Overview of Contemporary Translational Applications.
    Drinkenburg WH; Ruigt GS; Ahnaou A
    Neuropsychobiology; 2015; 72(3-4):151-64. PubMed ID: 26901596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical Decision Tree: a tool for studying pharmaco-EEG effects of CNS-active drugs.
    Dago KT; Luthringer R; Lengellé R; Rinaudo G; Macher JP
    Neuropsychobiology; 1994; 29(2):91-6. PubMed ID: 8170530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the recording and evaluation of pharmaco-EEG data in man: the International Pharmaco-EEG Society (IPEG).
    Jobert M; Wilson FJ; Ruigt GS; Brunovsky M; Prichep LS; Drinkenburg WH;
    Neuropsychobiology; 2012; 66(4):201-20. PubMed ID: 23075830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational psychiatry--light at the end of the tunnel.
    Jones KA; Menniti FS; Sivarao DV
    Ann N Y Acad Sci; 2015 May; 1344():1-11. PubMed ID: 25752480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary psychometric methods in pharmaco-electroencephalography research.
    Emegbo S; Hindmarch I
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():13. PubMed ID: 12809078
    [No Abstract]   [Full Text] [Related]  

  • 10. True alignment of preclinical and clinical research to enhance success in CNS drug development: a review of the current evidence.
    Goetghebeur PJ; Swartz JE
    J Psychopharmacol; 2016 Jul; 30(7):586-94. PubMed ID: 27147593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research.
    Leiser SC; Dunlop J; Bowlby MR; Devilbiss DM
    Biochem Pharmacol; 2011 Jun; 81(12):1408-21. PubMed ID: 20937262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the recording and evaluation of pharmaco-sleep studies in man: the International Pharmaco-EEG Society (IPEG).
    Jobert M; Wilson FJ; Roth T; Ruigt GS; Anderer P; Drinkenburg WH; Bes FW; Brunovsky M; Danker-Hopfe H; Freeman J; van Gerven JM; Gruber G; Kemp B; Klösch G; Ma J; Penzel T; Peterson BT; Schulz H; Staner L; Saletu B; Svetnik V;
    Neuropsychobiology; 2013; 67(3):127-67. PubMed ID: 23548759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correct assessment of new compounds using in vivo screening models can reduce false positives.
    Bueters TJ; Hoogstraate J; Visser SA
    Drug Discov Today; 2009 Jan; 14(1-2):89-94. PubMed ID: 18840543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of biomarkers in CNS drug development.
    Palmer AM
    Drug Discov Today; 2014 Mar; 19(3):201-3. PubMed ID: 24291786
    [No Abstract]   [Full Text] [Related]  

  • 15. [CNS drug research and development based on the human genetics and human biology].
    Hizue M
    Nihon Yakurigaku Zasshi; 2017; 149(4):154-159. PubMed ID: 28381658
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmaco-electroencephalography and pharmacokinetic/pharmacodynamic modeling in basic research: focus on human pharmacology.
    Valle M; Barbanoj MJ; Jané F
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():129-37. PubMed ID: 12575480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uses of pharmaco-EEG and pharmacokinetic-pharmacodynamic modeling in the clinical scenario.
    Barbanoj MJ; Valle M; Kulisevsky J; Pérez V; Gambús P
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():139-44. PubMed ID: 12575481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of mechanistic biomarkers for evaluating investigational CNS compounds in early drug development.
    Soares HD
    Curr Opin Investig Drugs; 2010 Jul; 11(7):795-801. PubMed ID: 20571975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of imaging biomarkers in the early clinical development of central nervous system therapeutic agents.
    Cole PE; Schwarz AJ; Schmidt ME
    Clin Pharmacol Ther; 2012 Feb; 91(2):315-20. PubMed ID: 22218072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine.
    Herrmann WM; Schärer E; Delini-Stula A
    Pharmacopsychiatry; 1991 Nov; 24(6):196-205. PubMed ID: 1687485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.